1. Product Overview
2. Research Methodology
3.
Executive Summary
4.
Voice of Customer
5.
Global Oncology Drugs Market Outlook
5.1. Market Size &
Forecast
5.1.1.
By Value
5.2. Market Share &
Forecast
5.2.1.
By Drug Type (Cytotoxic Drugs, Targeted Drugs,
Hormonal Drugs)
5.2.2.
By Therapy (Chemotherapy, Targeted Therapy,
Immunotherapy (Biologic Therapy), Hormonal Therapy, Others)
5.2.3.
By Drug Therapy (Adjuvant, Neoadjuvant and
Concurrent)
5.2.4.
By Route of Administration (Oral, Intravenous,
Subcutaneous, Others)
5.2.5.
By Gender (Male, Female)
5.2.6.
By Cancer Type (Lung Cancer, Stomach Cancer,
Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus
Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, Others)
5.2.7.
By Distribution Channel (Hospital Pharmacies,
Retail Pharmacies, Online Pharmacies, Government Hospitals)
5.2.8.
By Company (2019)
5.2.9.
By Region
5.3.
Market Attractiveness Index
6.
Asia-Pacific Oncology Drugs Market Outlook
6.1. Market Size &
Forecast
6.1.1.
By Value
6.2. Market Share &
Forecast
6.2.1.
By Drug Type
6.2.2.
By Therapy
6.2.3.
By Drug Therapy
6.2.4.
By Route of Administration
6.2.5.
By Gender
6.2.6.
By Cancer Type
6.2.7.
By Country
6.3. Asia-Pacific: Country
Analysis
6.3.1.
China Oncology Drugs Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Drug Type
6.3.1.2.2.
By Therapy
6.3.1.2.3.
By Drug Therapy
6.3.1.2.4.
By Route of Administration
6.3.1.2.5.
By Gender
6.3.1.2.6.
By Cancer Type
6.3.2.
India Oncology Drugs Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Drug Type
6.3.2.2.2.
By Therapy
6.3.2.2.3.
By Drug Therapy
6.3.2.2.4.
By Route of Administration
6.3.2.2.5.
By Gender
6.3.2.2.6.
By Cancer Type
6.3.3.
Japan Oncology Drugs Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Drug Type
6.3.3.2.2.
By Therapy
6.3.3.2.3.
By Drug Therapy
6.3.3.2.4.
By Route of Administration
6.3.3.2.5.
By Gender
6.3.3.2.6.
By Cancer Type
6.3.4.
South Korea Oncology Drugs Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Drug Type
6.3.4.2.2.
By Therapy
6.3.4.2.3.
By Drug Therapy
6.3.4.2.4.
By Route of Administration
6.3.4.2.5.
By Gender
6.3.4.2.6.
By Cancer Type
6.3.5.
Singapore Oncology Drugs Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Drug Type
6.3.5.2.2.
By Therapy
6.3.5.2.3.
By Drug Therapy
6.3.5.2.4.
By Route of Administration
6.3.5.2.5.
By Gender
6.3.5.2.6.
By Cancer Type
6.3.6.
Australia Oncology Drugs Market Outlook
6.3.6.1.
Market Size & Forecast
6.3.6.1.1.
By Value
6.3.6.2.
Market Share & Forecast
6.3.6.2.1.
By Drug Type
6.3.6.2.2.
By Therapy
6.3.6.2.3.
By Drug Therapy
6.3.6.2.4.
By Route of Administration
6.3.6.2.5.
By Gender
6.3.6.2.6.
By Cancer Type
7.
Europe Oncology Drugs Market Outlook
7.1. Market Size &
Forecast
7.1.1.
By Value
7.2. Market Share &
Forecast
7.2.1.
By Drug Type
7.2.2.
By Therapy
7.2.3.
By Drug Therapy
7.2.4.
By Route of Administration
7.2.5.
By Gender
7.2.6.
By Cancer Type
7.2.7.
By Country
7.3. Europe: Country Analysis
7.3.1.
France Oncology Drugs Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Drug Type
7.3.1.2.2.
By Therapy
7.3.1.2.3.
By Drug Therapy
7.3.1.2.4.
By Route of Administration
7.3.1.2.5.
By Gender
7.3.1.2.6.
By Cancer Type
7.3.2.
Germany Oncology Drugs Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Drug Type
7.3.2.2.2.
By Therapy
7.3.2.2.3.
By Drug Therapy
7.3.2.2.4.
By Route of Administration
7.3.2.2.5.
By Gender
7.3.2.2.6.
By Cancer Type
7.3.3.
United Kingdom Oncology Drugs Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Drug Type
7.3.3.2.2.
By Therapy
7.3.3.2.3.
By Drug Therapy
7.3.3.2.4.
By Route of Administration
7.3.3.2.5.
By Gender
7.3.3.2.6.
By Cancer Type
7.3.4.
Italy Oncology Drugs Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Drug Type
7.3.4.2.2.
By Therapy
7.3.4.2.3.
By Drug Therapy
7.3.4.2.4.
By Route of Administration
7.3.4.2.5.
By Gender
7.3.4.2.6.
By Cancer Type
7.3.5.
Spain Oncology Drugs Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Drug Type
7.3.5.2.2.
By Therapy
7.3.5.2.3.
By Drug Therapy
7.3.5.2.4.
By Route of Administration
7.3.5.2.5.
By Gender
7.3.5.2.6.
By Cancer Type
8.
North America Oncology Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1.
By Value
8.2. Market Share &
Forecast
8.2.1.
By Drug Type
8.2.2.
By Therapy
8.2.3.
By Drug Therapy
8.2.4.
By Route of Administration
8.2.5.
By Gender
8.2.6.
By Cancer Type
8.2.7.
By Country
8.3. North America: Country
Analysis
8.3.1.
United States Oncology Drugs Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Drug Type
8.3.1.2.2.
By Therapy
8.3.1.2.3.
By Drug Therapy
8.3.1.2.4.
By Route of Administration
8.3.1.2.5.
By Gender
8.3.1.2.6.
By Cancer Type
8.3.2.
Mexico Oncology Drugs Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Drug Type
8.3.2.2.2.
By Therapy
8.3.2.2.3.
By Drug Therapy
8.3.2.2.4.
By Route of Administration
8.3.2.2.5.
By Gender
8.3.2.2.6.
By Cancer Type
8.3.3.
Canada Oncology Drugs Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Drug Type
8.3.3.2.2.
By Therapy
8.3.3.2.3.
By Drug Therapy
8.3.3.2.4.
By Route of Administration
8.3.3.2.5.
By Gender
8.3.3.2.6.
By Cancer Type
9.
South America Oncology Drugs Market Outlook
9.1. Market Size &
Forecast
9.1.1.
By Value
9.2. Market Share &
Forecast
9.2.1.
By Drug Type
9.2.2.
By Therapy
9.2.3.
By Drug Therapy
9.2.4.
By Route of Administration
9.2.5.
By Gender
9.2.6.
By Cancer Type
9.2.7.
By Country
9.3. South America: Country
Analysis
9.3.1.
Brazil Oncology Drugs Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Drug Type
9.3.1.2.2.
By Therapy
9.3.1.2.3.
By Drug Therapy
9.3.1.2.4.
By Route of Administration
9.3.1.2.5.
By Gender
9.3.1.2.6.
By Cancer Type
9.3.2.
Argentina Oncology Drugs Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Drug Type
9.3.2.2.2.
By Therapy
9.3.2.2.3.
By Drug Therapy
9.3.2.2.4.
By Route of Administration
9.3.2.2.5.
By Gender
9.3.2.2.6.
By Cancer Type
9.3.3.
Colombia Oncology Drugs Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Drug Type
9.3.3.2.2.
By Therapy
9.3.3.2.3.
By Drug Therapy
9.3.3.2.4.
By Route of Administration
9.3.3.2.5.
By Gender
9.3.3.2.6.
By Cancer Type
10.
Middle East and Africa Oncology Drugs
Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1.
By Drug Type
10.2.2.
By Therapy
10.2.3.
By Drug Therapy
10.2.4.
By Route of Administration
10.2.5.
By Gender
10.2.6.
By Cancer Type
10.2.7. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa Oncology
Drugs Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Drug Type
10.3.1.2.2.
By Therapy
10.3.1.2.3.
By Drug Therapy
10.3.1.2.4.
By Route of Administration
10.3.1.2.5.
By Gender
10.3.1.2.6.
By Cancer Type
10.3.2. Saudi Arabia Oncology
Drugs Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Drug Type
10.3.2.2.2.
By Therapy
10.3.2.2.3.
By Drug Therapy
10.3.2.2.4.
By Route of Administration
10.3.2.2.5.
By Gender
10.3.2.2.6.
By Cancer Type
10.3.3. UAE Oncology Drugs
Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Drug Type
10.3.3.2.2.
By Therapy
10.3.3.2.3.
By Drug Therapy
10.3.3.2.4.
By Route of Administration
10.3.3.2.5.
By Gender
10.3.3.2.6.
By Cancer Type
10.3.4. Kuwait Oncology Drugs
Market Outlook
10.3.4.1.
Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2.
Market Share & Forecast
10.3.4.2.1.
By Drug Type
10.3.4.2.2.
By Therapy
10.3.4.2.3.
By Drug Therapy
10.3.4.2.4.
By Route of Administration
10.3.4.2.5.
By Gender
10.3.4.2.6.
By Cancer Type
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Patents (NDA, ANDA)
13. Market Trends &
Developments
14. Competitive Landscape
14.1.
Competition Outlook
14.2.
Players Profiled (Leading Companies)
14.2.1.
AbbVie Inc
14.2.2.
Roche Holding AG
14.2.3.
Novartis International AG
14.2.4.
Johnson & Johnson
14.2.5.
Bristol-Myers Squibb Company
14.2.6.
Celgene Corporation
14.2.7.
Merck & Co., Inc
14.2.8.
Pfizer Inc.
14.2.9.
Eli Lilly
14.2.10.
AstraZeneca PLC
14.2.11.
Takeda Pharmaceutical
14.2.12.
Amgen
14.2.13.
Astellas Pharma
14.2.14.
Sanofi
14.2.15.
Eisai
14.2.16.
Abbott
14.2.17.
Thermo Fisher Scientific
14.2.18.
Astex Pharmaceutical
14.2.19.
Daiichi Sankyo
14.2.20.
Teva Pharmaceutical
15. Strategic Recommendations
Figure 1: Global Oncology Drugs Size, By Value
(USD Million), 2015-2025F
Figure 2: Global Oncology Drugs Size, By Drug
Type (USD Million), 2015-2025F
Figure 3: Global Oncology Drugs Share, By Route
of Administration (USD Million), 2015-2025F
Figure 4: Global Oncology Drugs Share, By Drug
Therapy (USD Million), 2015-2025F
Figure 5: Global Oncology Drugs Share, By
Region (USD Million), 2015-2025F
Figure 6: Global Oncology Drugs Share, By
Company (USD Million), 2015-2025F
Figure 7: Global Oncology Drugs Attractiveness
Index, By Region, By Value, 2015-2025F
Figure 8: Global Oncology Drugs Attractiveness
Index, By Route of Administration Type, By Value, 2015-2025F
Figure 9: North America Oncology Drugs Size, By
Value (USD Million), 2015-2025F
Figure 10: North America Oncology Drugs Size,
By Drug Type (USD Million), 2015-2025F
Figure 11: North America Oncology Drugs Share,
By Route of Administration (USD Million), 2015-2025F
Figure 12: North America Oncology Drugs Share,
By Drug Therapy (USD Million), 2015-2025F
Figure 13: North America Oncology Drugs Share,
By Country (USD Million), 2015-2025F
Figure 14: North America Oncology Drugs
Attractiveness Index, By Country, By Value, 2015-2025F
Figure 15: North America Oncology Drugs
Attractiveness Index, By Route of Administration, By Value, 2015-2025F
Figure 16: United States Oncology Drugs Size,
By Value (USD Million), 2015-2025F
Figure 17: United States Oncology Drugs Size,
By Drug Type, 2015-2025F
Figure 18: United States Oncology Drugs Share,
By Route of Administration, 2015-2025F
Figure 19: United States Oncology Drugs Share,
By Drug Therapy, 2015-2025F
Figure 20: United States Oncology Drugs
Attractiveness Index, By Route of Administration, By Value, 2015-2025F
Figure 21: Canada Oncology Drugs Size, By Value
(USD Million), 2015-2025F
Figure 22: Canada Oncology Drugs Size, By Drug
Type, 2015-2025F
Figure 23: Canada Oncology Drugs Share, By
Route of Administration, 2015-2025F
Figure 24: Canada Oncology Drugs Share, By Drug
Therapy, 2015-2025F
Figure 25: Canada Oncology Drugs Attractiveness
Index, By Route of Administration, By Value, 2015-2025F
Figure 26: Mexico Oncology Drugs Size, By Value
(USD Million), 2015-2025F
Figure 27: Mexico Oncology Drugs Size, By Drug
Type, 2015-2025F
Figure 28: Mexico Oncology Drugs Share, By
Route of Administration, 2015-2025F
Figure 29: Mexico Oncology Drugs Share, By Drug
Therapy, 2015-2025F
Figure 30:
Mexico Oncology Drugs Attractiveness Index, By Route of Administration,
By Value, 2015-2025F
Figure 31: Europe Oncology Drugs Size, By Value
(USD Million), 2015-2025F
Figure 32:
Europe Oncology Drugs Size, By Drug Type (USD Million), 2015-2025F
Figure 33:
Europe Oncology Drugs Share, By Route of Administration (USD Million),
2015-2025F
Figure 34:
Europe Oncology Drugs Share, By Drug Therapy (USD Million), 2015-2025F
Figure 35: Europe Oncology Drugs Share, By
Country (USD Million), 2015-2025F
Figure 36: Europe Oncology Drugs Attractiveness
Index, By Country, By Value, 2015-2025F
Figure 37: Europe Oncology Drugs Attractiveness
Index, By Route of Administration, By Value, 2015-2025F
Figure 38:
Russia Oncology Drugs Size, By Value (USD Million), 2015-2025F
Figure 39: Russia Kingdom Oncology Drugs Size,
By Drug Type, 2015-2025F
Figure 40: Russia Oncology Drugs Share, By
Route of Administration, 2015-2025F
Figure 41:
Russia Oncology Drugs Share, By Drug Therapy, 2015-2025F
Figure 42:
Russia Oncology Drugs Attractiveness Index, By Route of Administration,
By Value, 2015-2025F
Figure 43: United Kingdom Oncology Drugs Size,
By Value (USD Million), 2015-2025F
Figure 44: United Kingdom Oncology Drugs Size,
By Drug Type, 2015-2025F
Figure 45: United Kingdom Oncology Drugs Share,
By Route of Administration, 2015-2025F
Figure 46: United Kingdom Oncology Drugs Share,
By Drug Therapy, 2015-2025F
Figure 47: United Kingdom Oncology Drugs
Attractiveness Index, By Route of Administration, By Value, 2015-2025F
Figure 48: Italy Oncology Drugs Size, By Value
(USD Million), 2015-2025F
Figure 49: Italy Oncology Drugs Size, By Drug
Type, 2015-2025F
Figure 50:
Italy Oncology Drugs Share, By Route of Administration, 2015-2025F
Figure 51: Italy Oncology Drugs Share, By Drug
Therapy, 2015-2025F
Figure 52: Italy Oncology Drugs Attractiveness
Index, By Route of Administration, By Value, 2015-2025F
Figure 53: Germany Oncology Drugs Size, By
Value (USD Million), 2015-2025F
Figure 54: Germany Oncology Drugs Size, By Drug
Type, 2015-2025F
Figure 55: Germany Oncology Drugs Share, By
Route of Administration, 2015-2025F
Figure 56: Germany Oncology Drugs Share, By
Drug Therapy, 2015-2025F
Figure 57: Germany Oncology Drugs
Attractiveness Index, By Route of Administration, By Value, 2015-2025F
Figure 58: Spain Oncology Drugs Size, By Value
(USD Million), 2015-2025F
Figure 59: Spain Oncology Drugs Size, By Drug
Type, 2015-2025F
Figure 60: Spain Oncology Drugs Share, By Route
of Administration, 2015-2025F
Figure 61: Spain Oncology Drugs Share, By Drug
Therapy, 2015-2025F
Figure 62: Spain Oncology Drugs Attractiveness
Index, By Route of Administration, By Value, 2015-2025F
Figure 63: France Oncology Drugs Size, By Value
(USD Million), 2015-2025F
Figure 64: France Oncology Drugs Size, By Drug
Type, 2015-2025F
Figure 65: France Oncology Drugs Share, By
Route of Administration, 2015-2025F
Figure 66: France Oncology Drugs Share, By Drug
Therapy, 2015-2025F
Figure 67: France Oncology Drugs Attractiveness
Index, By Route of Administration, By Value, 2015-2025F
Figure 68: Asia – Pacific Oncology Drugs Size,
By Value (USD Million), 2015-2025F
Figure 69: Asia – Pacific Oncology Drugs Size, By Drug Type(USD
Million), 2015-2025F
Figure 70: Asia – Pacific Oncology Drugs Share,
By Route of Administration (USD Million), 2015-2025F
Figure 71: Asia – Pacific Oncology Drugs Share,
By Drug Therapy (USD Million), 2015-2025F
Figure 72: Asia – Pacific Oncology Drugs Share,
By Country (USD Million), 2015-2025F
Figure 73: Asia – Pacific Oncology Drugs Attractiveness
Index, By Country, By Value, 2015-2025F
Figure 74: Asia – Pacific Oncology Drugs
Attractiveness Index, By Route of Administration, By Value, 2015-2025F
Figure 75: China Oncology Drugs Size, By Value
(USD Million), 2015-2025F
Figure 76:
China Oncology Drugs Size, By Drug Type, 2015-2025F
Figure 77: China Oncology Drugs Share, By Route
of Administration, 2015-2025F
Figure 78: China Oncology Drugs Share, By Drug
Therapy, 2015-2025F
Figure 79: China Oncology Drugs Share, By
Strength, 2015-2025F
Figure 80:
China Oncology Drugs Attractiveness Index, By Route of Administration,
By Value, 2015-2025F
Figure 81: India Oncology Drugs Size, By Value
(USD Million), 2015-2025F
Figure 82: India Oncology Drugs Size, By Drug
Type, 2015-2025F
Figure 83: India Oncology Drugs Share, By Route
of Administration, 2015-2025F
Figure 84: India Oncology Drugs Share, By Drug
Therapy, 2015-2025F
Figure 85: India Oncology Drugs Attractiveness
Index, By Route of Administration, By Value, 2015-2025F
Figure 86: Australia Oncology Drugs Size, By
Value (USD Million), 2015-2025F
Figure 87: Australia Oncology Drugs Size, By
Drug Type, 2015-2025F
Figure 88: Australia Oncology Drugs Share, By
Route of Administration, 2015-2025F
Figure 89: Australia Oncology Drugs Share, By
Drug Therapy, 2015-2025F
Figure 90: Australia Oncology Drugs
Attractiveness Index, By Route of Administration, By Value, 2015-2025F
Figure 91: Japan Oncology Drugs Size, By Value
(USD Million), 2015-2025F
Figure 92: Japan Oncology Drugs Size, By Drug
Type, 2015-2025F
Figure 93: Japan Oncology Drugs Share, By Route
of Administration, 2015-2025F
Figure 94: Japan Oncology Drugs Share, By Drug
Therapy, 2015-2025F
Figure 95: Japan Oncology Drugs Share, By
Strength, 2015-2025F
Figure 96:
Japan Oncology Drugs Attractiveness Index, By Route of Administration,
By Value, 2015-2025F
Figure 97: Singapore Oncology Drugs Size, By
Value (USD Million), 2015-2025F
Figure 98: Singapore Oncology Drugs Size, By
Drug Type, 2015-2025F
Figure 99: Singapore Oncology Drugs Share, By
Route of Administration, 2015-2025F
Figure 100: Singapore Oncology Drugs Share, By
Drug Therapy, 2015-2025F
Figure 101: Singapore Oncology Drugs
Attractiveness Index, By Route of Administration, By Value, 2015-2025F
Figure 102: South Korea Oncology Drugs Size, By
Value (USD Million), 2015-2025F
Figure 103: South Korea Oncology Drugs Size, By
Drug Type, 2015-2025F
Figure 104: South Korea Oncology Drugs Share,
By Route of Administration, 2015-2025F
Figure 105: South Korea Oncology Drugs Share,
By Drug Therapy, 2015-2025F
Figure 106: South Korea Oncology Drugs Share,
By Strength, 2015-2025F
Figure 107: South Korea Oncology Drugs
Attractiveness Index, By Route of Administration, By Value, 2015-2025F
Figure 108:
Middle East and Africa Oncology Drugs Size, By Value (USD Million),
2015-2025F
Figure 109:
Middle East and Africa Oncology Drugs Size, By Drug Type(USD Million),
2015-2025F
Figure 110:
Middle East and Africa Oncology Drugs Share, By Route of Administration
(USD Million), 2015-2025F
Figure 111: Middle East and Africa Oncology
Drugs Share, By Drug Therapy (USD Million), 2015-2025F
Figure 112: Middle East and Africa Oncology Drugs Share, By Country (USD
Million), 2015-2025F
Figure 113: Middle East and Africa Oncology
Drugs Attractiveness Index, By Country, By Value, 2015-2025F
Figure 114: Middle East and Africa Oncology
Drugs Attractiveness Index, By Route of Administration, By Value, 2015-2025F
Figure 115: Saudi Arabia Oncology Drugs Size,
By Value (USD Million), 2015-2025F
Figure 116: Saudi Arabia Oncology Drugs Size,
By Drug Type, 2015-2025F
Figure 117: Saudi Arabia Oncology Drugs Share,
By Route of Administration, 2015-2025F
Figure 118: Saudi Arabia Oncology Drugs Share,
By Drug Therapy, 2015-2025F
Figure 119: Saudi Arabia Oncology Drugs
Attractiveness Index, By Route of Administration, By Value, 2015-2025F
Figure 120: UAE Oncology Drugs Size, By Value
(USD Million), 2015-2025F
Figure 121: UAE Oncology Drugs Size, By Drug
Type, 2015-2025F
Figure 122: UAE Oncology Drugs Share, By Route
of Administration, 2015-2025F
Figure 123: UAE Oncology Drugs Share, By Drug
Therapy, 2015-2025F
Figure 124: UAE Oncology Drugs Share, By
Strength, 2015-2025F
Figure 125: UAE Oncology Drugs Attractiveness
Index, By Route of Administration, By Value, 2015-2025F
Figure 126: South Africa Oncology Drugs Size,
By Value (USD Million), 2015-2025F
Figure 127: South Africa Oncology Drugs Size,
By Drug Type, 2015-2025F
Figure 128: South Africa Oncology Drugs Share,
By Route of Administration, 2015-2025F
Figure 129: South Africa Oncology Drugs Share,
By Drug Therapy, 2015-2025F
Figure 130: South Africa Oncology Drugs Share,
By Strength, 2015-2025F
Figure 131: South Africa Oncology Drugs
Attractiveness Index, By Route of Administration, By Value, 2015-2025F
Figure 132: Kuwait Oncology Drugs Size, By
Value (USD Million), 2015-2025F
Figure 133: Kuwait Oncology Drugs Size, By Drug
Type, 2015-2025F
Figure 134: Kuwait Oncology Drugs Share, By
Route of Administration, 2015-2025F
Figure 135: Kuwait Oncology Drugs Share, By
Drug Therapy, 2015-2025F
Figure 136: Kuwait Oncology Drugs Share, By
Strength, 2015-2025F
Figure 137: Kuwait Oncology Drugs
Attractiveness Index, By Route of Administration, By Value, 2015-2025F
Figure 138:
South America Oncology Drugs Size, By Value (USD Million), 2015-2025F
Figure 139:
South America Oncology Drugs Size, By Drug Type (USD Million),
2015-2025F
Figure 140:
South America Oncology Drugs Share, By Route of Administration (USD
Million), 2015-2025F
Figure 141: South America Oncology Drugs Share,
By Drug Therapy (USD Million), 2015-2025F
Figure 142: South America Oncology Drugs Share,
By Country (USD Million), 2015-2025F
Figure 143: South America Oncology Drugs
Attractiveness Index, By Country, By Value, 2015-2025F
Figure 144: South America Oncology Drugs
Attractiveness Index, By Route of Administration, By Value, 2015-2025F
Figure 145: Brazil Oncology Drugs Size, By Value
(USD Million), 2015-2025F
Figure 146: Brazil Oncology Drugs Size, By Drug
Type, 2015-2025F
Figure 147: Brazil Oncology Drugs Share, By
Route of Administration, 2015-2025F
Figure 148: Brazil Oncology Drugs Share, By
Drug Therapy, 2015-2025F
Figure 149: Brazil Oncology Drugs Share, By
Strength, 2015-2025F
Figure 150: Brazil Oncology Drugs
Attractiveness Index, By Route of Administration, By Value, 2015-2025F
Figure 151: Argentina Oncology Drugs Size, By
Value (USD Million), 2015-2025F
Figure 152: Argentina Oncology Drugs Size, By
Drug Type, 2015-2025F
Figure 153: Argentina Oncology Drugs Share, By
Route of Administration, 2015-2025F
Figure 154: Argentina Oncology Drugs Share, By
Drug Therapy, 2015-2025F
Figure 155: Argentina Oncology Drugs
Attractiveness Index, By Route of Administration, By Value, 2015-2025F
Figure 156: Colombia Oncology Drugs Size, By
Value (USD Million), 2015-2025F
Figure 157: Colombia Oncology Drugs Size, By
Drug Type, 2015-2025F
Figure 158: Colombia Oncology Drugs Share, By
Route of Administration, 2015-2025F
Figure 159: Colombia Oncology Drugs Share, By
Drug Therapy, 2015-2025F
Figure 160: Colombia Oncology Drugs Share, By
Strength, 2015-2025F
Figure 161: Colombia
Oncology Drugs Attractiveness Index, By Route of Administration, By Value,
2015-2025F